Company intelligence / Profile preview

Medicis Aesthetics

Scottsdale, Arizona, United Stateswmagazine.com ↗
Ownership
Private
Employees
~550
Development stage
Commercial
01

Overview

Prior to its acquisition by Valeant in late 2012/early2013 for $2.6 billion, Medicis was a leading specialty pharmaceutical company focused on dermatology and aesthetic medicine. Its commercial portfolio included acne treatments and injectable dermal fillers such as Restylane and Perlane. The company also expanded into body contouring with the acquisition of LipoSonix technology.[1][2][3][5] Clinical results for its marketed products were well established; new pipeline programs were not widely publicized at the time of acquisition.

Therapeutic areas
Dermatology
Modalities
Small molecules (acne, dermatology drugs)Injectable dermal fillers (hyaluronic acid-based, e.g., Restylane, Perlane)Body contouring devices/technologies (e.g., LipoSonix ultrasound device)[5][7]
Industry
Biotech
02

Drug pipeline

1 asset

Restylane

Commercial
Indications
Facial wrinkles, Fine lines, Dermal volume loss
03

Partnerships

Q-Med AB/Galderma S.A. – licensing/distribution agreement for Restylane/Perlane in North America [6][8]

Beyond the preview

Go deeper on Medicis Aesthetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicis Aesthetics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call